Zhang Ling, Feng Yuying, Fu Ping
Division of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China.
Precis Clin Med. 2021 Feb 25;4(1):45-55. doi: 10.1093/pcmedi/pbab005. eCollection 2021 Mar.
Sepsis is a life-threatening organ failure exacerbated by a maladaptive infection response from the host, and is one of the major causes of mortality in the intensive care unit. In recent decades, several extracorporeal blood purification techniques have been developed to manage sepsis by acting on both the infectious agents themselves and the host immune response. This research aims to summarize recent progress on extracorporeal blood purification technologies applied for sepsis, discuss unanswered questions on renal replacement therapy for septic patients, and present a decision-making strategy for practitioners.
脓毒症是一种由宿主适应性感染反应加剧而导致的危及生命的器官功能衰竭,是重症监护病房死亡的主要原因之一。近几十年来,已经开发了几种体外血液净化技术,通过作用于感染因子本身和宿主免疫反应来治疗脓毒症。本研究旨在总结应用于脓毒症的体外血液净化技术的最新进展,讨论脓毒症患者肾脏替代治疗中尚未解决的问题,并为从业者提出一种决策策略。